Financials

News Ideas Discussions Technicals Seasonals

TELO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Telo Genomics Corp. is a molecular diagnostics company, which engages in the development of telomere analysis platforms in the industry. Its products include Telomere Science and Teloview. The company was founded by Sabine Mai on May 25, 2011 and is headquartered in Toronto, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

TELO has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company